Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Upper Respiratory Tract Infection
85%
Acute Diarrhea
56%
Systemic Lupus Erythematosus
56%
Comorbidity
42%
Physical Disease by Body Function
37%
Infection
37%
Antibiotics
33%
Maternal Mortality
28%
Maternal Death
28%
Pneumococcus Vaccine
28%
Lung Embolism
28%
Blood Clotting Disorder
28%
Liver Injury
28%
Overall Survival
28%
Pancreas Cancer
28%
Retroperitoneal Tumor
28%
COVID-19 Vaccine
28%
Cerebrovascular Accident
28%
Urinary Tract Infection
28%
Rhinorrhea
28%
Drug Resistant Epilepsy
28%
Sore Throat
28%
Tuberous Sclerosis
28%
Cognitive Defect
23%
Weakness
21%
Central Nervous System Infection
18%
Neurological Complication
18%
Liver Enzyme
17%
Mood Disorder
14%
Antiphospholipid Syndrome
14%
Side Effect
11%
Isoniazid
11%
Headache
11%
Cross-Sectional Study
10%
Anxiety Disorder
9%
Mortality Rate
9%
Virus Strain
9%
Cannabidiol
9%
Anticonvulsive Agent
9%
Symptomatic Epilepsy
9%
Hospital Mortality
8%
Sentinel Surveillance
7%
Clinical Feature
7%
Median Survival Time
7%
Deterioration
5%
Antimicrobial Resistance
5%
Sepsis
5%
Acute Kidney Failure
5%
Bilirubin
5%
Medicine and Dentistry
Upper Respiratory Tract Infection
56%
Ambulatory Care
33%
Intensive Care Unit
32%
Primary Health Care
31%
Low Drug Dose
28%
Pneumococcus Vaccine
28%
Observational Study
28%
Acute Diarrhea
28%
Family Practice
28%
Pulmonary Embolism
28%
Overall Survival
28%
Pancreas Cancer
28%
Low and Middle Income Countries
28%
Health Care Cost
28%
Retroperitoneal Tumor
28%
Mental Disorder
28%
Systemic Lupus Erythematosus
28%
COVID-19 Vaccine
28%
Neurologic Finding
28%
Soft Tissue Sarcoma
28%
Demyelinating Disorder
28%
Tuberous Sclerosis
28%
COVID-19
28%
Drug Resistant Epilepsy
28%
Emergency Care System
28%
Coagulopathy
24%
Apoplexy
24%
Epileptic Seizure
24%
Integrated Management of Childhood Illness
23%
Cognitive Defect
18%
Central Nervous System Infection
16%
Neurological Complication
16%
Obstetric Complication
14%
Birth Rate
14%
Booster Dose
14%
Univariate Analysis
14%
Disease Outbreaks
14%
Intensive Care
14%
Bivariate Analysis
14%
Antiphospholipid Syndrome
14%
Emergency Care
14%
Health Disparity
14%
Cross Sectional Study
14%
Case Fatality Rate
11%
Clinical Stage
11%
Headache
11%
Injection Site
11%
Antiinfective Agent
9%
Mood Disorder
9%
Health Outcomes
9%
Nursing and Health Professions
Intensive Care Unit
32%
Immunoglobulin
28%
Cost Effectiveness Analysis
28%
Disease Burden
28%
Primary Health Care
28%
Upper Respiratory Tract Infection
28%
Patient Compliance
28%
Systemic Lupus Erythematosus
28%
Overall Survival
28%
Pancreas Cancer
28%
Blood Clotting Disorder
28%
Retroperitoneal Tumor
28%
Health Economics
28%
Ambulatory Care
28%
Acute Diarrhea
28%
Health Center
28%
Sore Throat
28%
Coughing
28%
Wheezing
28%
Rhinorrhea
28%
Dyspnea
28%
Primary Medical Care
14%
Health Practitioner
14%
Bivariate Analysis
14%
Cross-Sectional Study
14%
Univariate Analysis
14%
Health Care Personnel
14%
Case Fatality Rate
11%
Infection
9%
Preventive Health Service
9%
Immunization Registry
9%
Health Outcomes
9%
Hospital Mortality
8%
Odds Ratio
8%
Median Survival Time
7%
ICD-10
7%
Log Rank Test
7%
Disease Severity
5%
Connective Tissue Cancer
5%
Recurrent Disease
5%
Cost of Illness
5%
Electronic Health Record
5%
Health Care Planning
5%
